Adial Pharmaceuticals Inc (ADIL): Congress and insider trades

Who in Congress and inside the company traded ADIL, when each filing appeared, and what buying after each one would have earned against the S&P 500.

Key Facts

  • Adial Pharmaceuticals Inc (ADIL) is a listed stock on NASDAQ.
  • Insiders filed 5 open market buys worth $106K and 0 sells worth $0, the latest filed 2026-07-16 (16 July 2026).
  • Data as of 2026-09-29 (29 September 2026).
Congress buys 0 0 members
Congress sells 0
Insider buys 5 $106K
Insider sells 0 $0
Congress buys vs S&P, 90d n/a 0 scored buys
Insider buys vs S&P, 90d n/a 0 scored buys

Insider trades in ADIL

as of 2026-07-16
Open market insider trades in ADIL, newest first.
FiledInsiderTypeSharesPriceValue90 day vs S&P
16 Jul 2026 Coastlands Capital LP buy 2,000 $2.65 $5.3K n/a
16 Jul 2026 Coastlands Capital LP buy 1,233 $2.75 $3.4K n/a
13 Jul 2026 Coastlands Capital LP buy 10,053 $2.79 $28.0K n/a
13 Jul 2026 Coastlands Capital LP buy 1,700 $2.70 $4.6K n/a
1 Jul 2026 Coastlands Capital LP buy 25,000 $2.60 $65.0K n/a

Frequently asked questions

Who has bought ADIL?

0 Congress buys by 0 members and 5 insider buys are on file. The tables on this page list every one.

Did buying ADIL after a disclosure beat the market?

No disclosed buy of this stock has matured 90 days yet. A single stock is a small sample.

Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.